All samples·Sample analysis
Get your own pass — $199
granted.bioAll samples
Analysis

radioligand therapy for prostate cancer

Overview
  • Dashboard
Analysis
  • What Surprised Us
  • Field Maturity
  • Funding Landscape
  • Competitive Topology
  • White Space
  • Market Context
Data
  • Projects115
  • Clinical Trials500
  • Patents29
  • Publications646
  • Organizations52
  • Researchers125
Reference
  • Methodology
Back
radioligand therapy for prostate cancerOrganizationsUT SOUTHWESTERN MEDICAL CENTER

UT SOUTHWESTERN MEDICAL CENTER

Projects attributed to UT SOUTHWESTERN MEDICAL CENTER within this analysis sample.

In This Analysis
Projects
2
NIH Funding
$4.2M
Projects(2)
ProjectPICategoryFunding
Multimodal dendrimer theranostics targeting aggressive subtypes of prostate cancer
R01CA285792
POMPER, MARTIN GTherapeutics$3.4M
Enhanced imaging and treatment of aggressive subtypes of prostate cancer
5R01CA134675-16
POMPER, MARTIN GTherapeutics$857K
See UT SOUTHWESTERN MEDICAL CENTER’s full platform profile
Cross-source view across the entire granted.bio dataset — projects, trials, patents, and publications spanning every topic, not just this analysis.